Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Orient EuroPharma Co. Ltd.

www.oep.com.tw/en-global

Latest From Orient EuroPharma Co. Ltd.

Deals Shaping the Medical Industry, August 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in July 2016.

Market Intelligence Deals

UCB Links With Daiichi Sankyo For Epilepsy In Japan

UCB has chosen Daiichi Sankyo as its new commercial partner in Japan for an epilepsy drug, building on an existing relationship in the allergy area.

BioPharmaceutical Japan

Deals Shaping The Medical Industry, July/August 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced May and June 2014.

BioPharmaceutical Medical Device

Success Hinging On Single Platforms For Kissei, Dainippon Sumitomo, NanoCarrier and Eisai: Japan Earnings Roundup (Part 2)

A look at key products that could determine the year ahead for Japanese pharma.

BioPharmaceutical Japan
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
    • Nutraceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Dermatology
  • Gynecological, Urological
  • Immune Disorders
  • Metabolic Disorders
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Taiwan
  • Parent & Subsidiaries
  • Orient EuroPharma Co. Ltd.
  • Senior Management
  • Peter Tsai, Pres. & CEO
  • Contact Info
  • Orient EuroPharma Co. Ltd.
    Phone: (886) 2 27554881
    7F, No.368, Sec.1
    Fu Hsing S. Rd.
    Taipei,
    Taiwan
Advertisement
Advertisement
UsernamePublicRestriction

Register